Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-29 07:06 am Purchase |
2020-12-31 | 13G | Arcadia Biosciences, Inc. RKDA |
Mitchell P. Kopin | 18,633 5.300% |
2,986 (+19.09%) |
Filing History |
| 2021-01-29 07:04 am Purchase |
2020-12-31 | 13G | Pulmatrix, Inc. PULM |
Mitchell P. Kopin | 118,500 6.400% |
59,844 (+102.03%) |
Filing History |
| 2021-01-29 07:03 am Sale |
2020-12-31 | 13G | Top Ships Inc. TOPS |
Mitchell P. Kopin | 75 0.040% |
-3,675 (-98.00%) |
Filing History |
| 2021-01-29 07:02 am Purchase |
2020-12-31 | 13G | Check-Cap Ltd. CHEK |
Mitchell P. Kopin | 154,070 6.200% |
129,845 (+536.00%) |
Filing History |
| 2021-01-29 07:00 am Purchase |
2020-12-31 | 13G | Kintara Therapeutics, Inc. KTRA |
Mitchell P. Kopin | 514 3.500% |
514 (New Position) |
Filing History |
| 2021-01-29 06:58 am Purchase |
2020-12-31 | 13G | InspireMD, Inc. NSPR |
Mitchell P. Kopin | 96,511 3.800% |
70,070 (+265.00%) |
Filing History |
| 2021-01-29 06:56 am Sale |
2020-12-31 | 13G | Oragenics, Inc. OGEN |
Mitchell P. Kopin | 89,500,020 1.600% |
-110,500,020 (-55.25%) |
Filing History |
| 2021-01-29 06:54 am Sale |
2020-12-31 | 13G | Plus Therapeutics, Inc. PSTV |
Mitchell P. Kopin | 20,000 5.900% |
-7,039 (-26.03%) |
Filing History |
| 2021-01-29 06:53 am Sale |
2020-12-31 | 13G | Aethlon Medical, Inc. AEMD |
Mitchell P. Kopin | 17,912 1.500% |
-14,497 (-44.73%) |
Filing History |
| 2021-01-29 06:51 am Purchase |
2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Mitchell P. Kopin | 329,116,500 6.600% |
325,475,470 (+8939.10%) |
Filing History |
| 2021-01-29 06:49 am Sale |
2020-12-31 | 13G | TD Holdings, Inc. GLG |
Mitchell P. Kopin | 2,040 0.600% |
-1,652 (-44.75%) |
Filing History |
| 2021-01-29 06:46 am Unchanged |
2020-12-31 | 13G | XWELL, Inc. XWEL |
Mitchell P. Kopin | 247,561 5.000% |
0 (Unchanged) |
Filing History |
| 2021-01-29 06:41 am Sale |
2020-12-31 | 13G | Singularity Future Technology Ltd. SGLY |
Mitchell P. Kopin | 22,500 3.600% |
-9,507 (-29.70%) |
Filing History |
| 2021-01-29 06:39 am Purchase |
2020-12-31 | 13G | Aeterna Zentaris Inc. AEZS |
Mitchell P. Kopin | 839 5.400% |
314 (+59.92%) |
Filing History |
| 2021-01-29 06:36 am Sale |
2020-12-31 | 13G | Recon Technology, Ltd. RCON |
Mitchell P. Kopin | 16,389 3.900% |
-12,236 (-42.75%) |
Filing History |
| 2021-01-29 06:34 am Unchanged |
2020-12-31 | 13G | BIOLASE, Inc. BIOL |
Mitchell P. Kopin | 2,298 5.800% |
0 (Unchanged) |
Filing History |
| 2021-01-29 06:33 am Sale |
2020-12-31 | 13G | Ra Medical Systems, Inc. RMED |
Mitchell P. Kopin | 3,052 4.970% |
-647 (-17.50%) |
Filing History |
| 2021-01-29 06:32 am Sale |
2020-12-31 | 13G | Iterum Therapeutics plc ITRM |
Mitchell P. Kopin | 171,852 4.990% |
-7,802 (-4.34%) |
Filing History |
| 2021-01-29 06:31 am Unchanged |
2020-12-31 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Mitchell P. Kopin | 24,324 7.500% |
0 (Unchanged) |
Filing History |
| 2021-01-29 06:27 am Purchase |
2020-12-31 | 13G | Globus Maritime Limited GLBS |
Mitchell P. Kopin | 334,459 9.990% |
334,459 (New Position) |
Filing History |